Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $160.4 million.

  • Mirum Pharmaceuticals' Total Current Liabilities rose 3853.79% to $160.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.4 million, marking a year-over-year increase of 3853.79%. This contributed to the annual value of $126.6 million for FY2024, which is 4535.4% up from last year.
  • Mirum Pharmaceuticals' Total Current Liabilities amounted to $160.4 million in Q3 2025, which was up 3853.79% from $144.8 million recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Total Current Liabilities high stood at $160.4 million for Q3 2025, and its period low was $29.0 million during Q2 2021.
  • Its 5-year average for Total Current Liabilities is $79.7 million, with a median of $64.7 million in 2022.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 16813.01% in 2021, then tumbled by 133.92% in 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' Total Current Liabilities (Quarter) stood at $42.6 million in 2021, then skyrocketed by 51.96% to $64.7 million in 2022, then surged by 34.51% to $87.1 million in 2023, then skyrocketed by 45.35% to $126.6 million in 2024, then grew by 26.71% to $160.4 million in 2025.
  • Its Total Current Liabilities stands at $160.4 million for Q3 2025, versus $144.8 million for Q2 2025 and $127.6 million for Q1 2025.